Abstract
In muscle tissue there is a balance between the processes muscle synthesis and degradation. The mammalian target of rapamycin (mTOR) signaling pathway plays a critical role in regulating protein synthesis in order to maintain muscular protein turnover and trophism. Studies have shown that both down- and upregulation mechanisms are involved in this process in a manner dependent on stimulus and cellular conditions. Additionally, mTOR signaling has recently been implicated in several physiological conditions related to cell survival, such as self-digestion (autophagy), energy production, and the preservation of cellular metabolic balance over the lifespan. Here we briefly describe the mTOR structure and its regulatory protein synthesis pathway. Furthermore, the role of mTOR protein in autophagy, aging, and mitochondrial function in muscle tissue is presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baroni BM, Rodrigues R, Franke RA, Geremia JM, Rassier DE, Vaz MA (2013) Time course of neuromuscular adaptations to knee extensor eccentric training. Int J Sports Med 34(10):904–911. https://doi.org/10.1055/s-0032-1333263
Kern H, Hofer C, Loefler S, Zampieri S, Gargiulo P, Baba A et al (2017) Atrophy, ultra-structural disorders, severe atrophy and degeneration of denervated human muscle in SCI and aging. Implications for their recovery by functional electrical stimulation, updated 2017. Neurol Res 39(7):660–666. https://doi.org/10.1080/01616412.2017.1314906
Suetta C (2017) Plasticity and function of human skeletal muscle in relation to disuse and rehabilitation: influence of ageing and surgery. Dan Med J 64(8):B5377
Lundell LS, Savikj M, Kostovski E, Iversen PO, Zierath JR, Krook A et al (2018) Protein translation, proteolysis and autophagy in human skeletal muscle atrophy after spinal cord injury. Acta Physiol (Oxf) 223:e13051. https://doi.org/10.1111/apha.13051
Léger B, Cartoni R, Praz M, Lamon S, Dériaz O, Crettenand A et al (2006) Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 576(Pt 3):923–933. https://doi.org/10.1113/jphysiol.2006.116715
Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R et al (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3(11):1014–1019. https://doi.org/10.1038/ncb1101-1014
Dreyer HC, Glynn EL, Lujan HL, Fry CS, DiCarlo SE, Rasmussen BB (2008) Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway. J Appl Physiol (1985) 104(1):27–33. https://doi.org/10.1152/japplphysiol.00736.2007
Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451(7182):1069–1075. https://doi.org/10.1038/nature06639
Vézina C, Kudelski A, Sehgal SN (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28(10):721–726
Heitman J, Movva NR, Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253(5022):905–909
Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN (1993) Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73(3):585–596
Chiu MI, Katz H, Berlin V (1994) RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc Natl Acad Sci U S A 91(26):12574–12578
Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18(16):1926–1945. https://doi.org/10.1101/gad.1212704
Peterson RT, Beal PA, Comb MJ, Schreiber SL (2000) FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 275(10):7416–7423
Gingras AC, Raught B, Sonenberg N (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev 15(7):807–826. https://doi.org/10.1101/gad.887201
Perry J, Kleckner N (2003) The ATRs, ATMs, and TORs are giant HEAT repeat proteins. Cell 112(2):151–155
Soliman GA, Acosta-Jaquez HA, Dunlop EA, Ekim B, Maj NE, Tee AR et al (2010) mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action. J Biol Chem 285(11):7866–7879. https://doi.org/10.1074/jbc.M109.096222
Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D et al (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 7(2):e38. https://doi.org/10.1371/journal.pbio.1000038
Miyazaki M, Esser KA (2009) Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J Appl Physiol (1985) 106(4):1367–1373. https://doi.org/10.1152/japplphysiol.91355.2008
Jordan NJ, Dutkowski CM, Barrow D, Mottram HJ, Hutcheson IR, Nicholson RI et al (2014) Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Res 16(1):R12. https://doi.org/10.1186/bcr3604
Sandri M (2008) Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23:160–170. https://doi.org/10.1152/physiol.00041.2007
Smerdon SJ (2014) A year in structural signaling: mTOR–the PIKK of the bunch? Sci Signal 7(315):pe6. https://doi.org/10.1126/scisignal.2005174
Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9(10):747–758. https://doi.org/10.1038/nrm2509
Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y et al (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280(4):2737–2744. https://doi.org/10.1074/jbc.M407517200
Reid MB (2005) Response of the ubiquitin-proteasome pathway to changes in muscle activity. Am J Physiol Regul Integr Comp Physiol 288(6):R1423–R1431. https://doi.org/10.1152/ajpregu.00545.2004
Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S (2002) A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci U S A 99(14):9213–9218. https://doi.org/10.1073/pnas.142166599
Laplante M, Sabatini DM (2012) mTOR Signaling. Cold Spring Harb Perspect Biol 4(2):a011593. https://doi.org/10.1101/cshperspect.a011593
Krieg J, Hofsteenge J, Thomas G (1988) Identification of the 40 S ribosomal protein S6 phosphorylation sites induced by cycloheximide. J Biol Chem 263(23):11473–11477
Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G (1997) Rapamycin suppresses 5’TOP mRNA translation through inhibition of p70s6k. EMBO J 16(12):3693–3704. https://doi.org/10.1093/emboj/16.12.3693
Kawasome H, Papst P, Webb S, Keller GM, Johnson GL, Gelfand EW et al (1998) Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc Natl Acad Sci U S A 95(9):5033–5038
Hershey JWB, Merrick WC (2000) Pathway and mechanism of initiation of protein synthesis. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational control of gene expression. Cold Spring Harbor Laboratory Press, New York, pp 33–88
Wang X, Regufe da Mota S, Liu R, Moore CE, Xie J, Lanucara F et al (2014) Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Mol Cell Biol 34(22):4088–4103. https://doi.org/10.1128/MCB.01035-14
Ma XM, Blenis J (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10(5):307–318. https://doi.org/10.1038/nrm2672
Marcotrigiano J, Gingras AC, Sonenberg N, Burley SK (1999) Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol Cell 3(6):707–716
Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN et al (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3(11):1009–1013. https://doi.org/10.1038/ncb1101-1009
Goodman CA, Frey JW, Mabrey DM, Jacobs BL, Lincoln HC, You JS et al (2011) The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol 589(Pt 22):5485–5501. https://doi.org/10.1113/jphysiol.2011.218255
Dreyer HC, Fujita S, Cadenas JG, Chinkes DL, Volpi E, Rasmussen BB (2006) Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol 576(Pt 2):613–624. https://doi.org/10.1113/jphysiol.2006.113175
Wilkinson SB, Phillips SM, Atherton PJ, Patel R, Yarasheski KE, Tarnopolsky MA et al (2008) Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. J Physiol 586(15):3701–3717. https://doi.org/10.1113/jphysiol.2008.153916
Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E et al (2005) Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol 7(3):286–294. https://doi.org/10.1038/ncb1231
Ogasawara R, Fujita S, Hornberger TA, Kitaoka Y, Makanae Y, Nakazato K et al (2016) The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise. Sci Rep 6:31142. https://doi.org/10.1038/srep31142
Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE et al (1997) Contraction-induced changes in acetyl-CoA carboxylase and 5’-AMP-activated kinase in skeletal muscle. J Biol Chem 272(20):13255–13261
Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ (2001) AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280(5):E677–E684. https://doi.org/10.1152/ajpendo.2001.280.5.E677
Ogasawara R, Sato K, Matsutani K, Nakazato K, Fujita S (2014) The order of concurrent endurance and resistance exercise modifies mTOR signaling and protein synthesis in rat skeletal muscle. Am J Physiol Endocrinol Metab 306(10):E1155–E1162. https://doi.org/10.1152/ajpendo.00647.2013
West DW, Baehr LM, Marcotte GR, Chason CM, Tolento L, Gomes AV et al (2016) Acute resistance exercise activates rapamycin-sensitive and -insensitive mechanisms that control translational activity and capacity in skeletal muscle. J Physiol 594(2):453–468. https://doi.org/10.1113/JP271365
Pardo OE, Seckl MJ (2013) S6K2: the neglected S6 kinase family member. Front Oncol 3:191. https://doi.org/10.3389/fonc.2013.00191
Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J et al (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24(8):3112–3124
Valovka T, Verdier F, Cramer R, Zhyvoloup A, Fenton T, Rebholz H et al (2003) Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization. Mol Cell Biol 23(3):852–863
Sanchez AM, Bernardi H, Py G, Candau RB (2014) Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise. Am J Physiol Regul Integr Comp Physiol 307(8):R956–R969. https://doi.org/10.1152/ajpregu.00187.2014
Kennedy BK, Lamming DW (2016) The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging. Cell Metab 23(6):990–1003. https://doi.org/10.1016/j.cmet.2016.05.009
Weichhart T (2018) mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology 64(2):127–134. https://doi.org/10.1159/000484629
Dasuri K, Zhang L, Keller JN (2013) Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med 62:170–185. https://doi.org/10.1016/j.freeradbiomed.2012.09.016
Perluigi M, Di Domenico F, Butterfield DA (2015) mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis 84:39–49. https://doi.org/10.1016/j.nbd.2015.03.014
Castets P, Rüegg MA (2013) MTORC1 determines autophagy through ULK1 regulation in skeletal muscle. Autophagy 9(9):1435–1437. https://doi.org/10.4161/auto.25722
Pagano AF, Py G, Bernardi H, Candau RB, Sanchez AM (2014) Autophagy and protein turnover signaling in slow-twitch muscle during exercise. Med Sci Sports Exerc 46(7):1314–1325. https://doi.org/10.1249/MSS.0000000000000237
Møller AB, Vendelbo MH, Christensen B, Clasen BF, Bak AM, Jørgensen JO et al (2015) Physical exercise increases autophagic signaling through ULK1 in human skeletal muscle. J Appl Physiol (1985) 118(8):971–979. https://doi.org/10.1152/japplphysiol.01116.2014
Fritzen AM, Madsen AB, Kleinert M, Treebak JT, Lundsgaard AM, Jensen TE et al (2016) Regulation of autophagy in human skeletal muscle: effects of exercise, exercise training and insulin stimulation. J Physiol 594(3):745–761. https://doi.org/10.1113/JP271405
Tan VP, Miyamoto S (2016) Nutrient-sensing mTORC1: integration of metabolic and autophagic signals. J Mol Cell Cardiol 95:31–41. https://doi.org/10.1016/j.yjmcc.2016.01.005
Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450(7170):736–740. https://doi.org/10.1038/nature06322
Scarpulla RC (2011) Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813(7):1269–1278. https://doi.org/10.1016/j.bbamcr.2010.09.019
Schieke SM, Finkel T (2007) TOR and aging: less is more. Cell Metab 5(4):233–235. https://doi.org/10.1016/j.cmet.2007.03.005
Schieke SM, Phillips D, McCoy JP, Aponte AM, Shen RF, Balaban RS et al (2006) The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281(37):27643–27652. https://doi.org/10.1074/jbc.M603536200
Finley LW, Haigis MC (2009) The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res Rev 8(3):173–188. https://doi.org/10.1016/j.arr.2009.03.003
Sack MN, Finkel T (2012) Mitochondrial metabolism, sirtuins, and aging. Cold Spring Harb Perspect Biol 4(12):a013102. https://doi.org/10.1101/cshperspect.a013102
Johnson ML, Robinson MM, Nair KS (2013) Skeletal muscle aging and the mitochondrion. Trends Endocrinol Metab 24(5):247–256. https://doi.org/10.1016/j.tem.2012.12.003
Russell AP, Foletta VC, Snow RJ, Wadley GD (2014) Skeletal muscle mitochondria: a major player in exercise, health and disease. Biochim Biophys Acta 1840(4):1276–1284. https://doi.org/10.1016/j.bbagen.2013.11.016
Carter HN, Chen CC, Hood DA (2015) Mitochondria, muscle health, and exercise with advancing age. Physiology (Bethesda) 30(3):208–223. https://doi.org/10.1152/physiol.00039.2014
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ilha, J., do Espírito-Santo, C.C., de Freitas, G.R. (2018). mTOR Signaling Pathway and Protein Synthesis: From Training to Aging and Muscle Autophagy. In: Xiao, J. (eds) Muscle Atrophy. Advances in Experimental Medicine and Biology, vol 1088. Springer, Singapore. https://doi.org/10.1007/978-981-13-1435-3_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-1435-3_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1434-6
Online ISBN: 978-981-13-1435-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)